Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat

Anesthesiology

Volumn 87, Issue 3, 1997, Pages 577-584

  Nakamura, Isao ^b   Ohta, Yoshihiro ^a   Kemmotsu, Osamu ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NONE

Author keywords

Receptors, adenosine, agonists: CGS 21680; N6 cyclohexyladenosine; 5' N ethylcarboxamidoadenosine; N6 (R) phenylisopropyladenosine; Receptors, adenosine, antagonists: 8 cyclopentyltheophylline; theophylline; Spinal cord: nociception

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLOHEXYLADENOSINE; PHENYLISOPROPYLADENOSINE;

ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; EVOKED RESPONSE; FEMALE; MALE; MONOSYNAPTIC REFLEX; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; VENTRAL ROOT;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; PAIN; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; REFLEX, MONOSYNAPTIC; SPINAL CORD; THEOPHYLLINE;

EID: 0030747136     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199709000-00018     Document Type: Article

References (41)

1. Snyder SH: Adenosine as a neuromodulator. Ann Rev Neurosci 1985; 8: 103-24
2. Sawynok J, Sweeney MI: The role of purines in nociception. Neuroscience 1989; 32: 557-69
3. Sawynok, J, Sweeney MI, White TD: Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br J Pharmacol 1986; 88: 923-30
4. DeLander GE, Hopkins CJ: Involvement of A2 adenosine receptors in spinal mechanisms of antinociecption. European J Pharmacol 1987; 139: 215-23
5. Karlsten R, Gordh TJ, Hartvig P, Post C: Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat. Anesth Analg 1990; 71: 60-4
6. 3H]NECA in rat striatal membranes. Mol Pharmacol 1986; 29: 331-46
7. Londos C, Cooper DMF, Wolff J: Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A 1980; 77: 2551-4
8. Choca JI, Proudfit HK, Green RD: Identification of A1 and A2 adenosine receptors in the rat spinal cord. J Pharmacol Exp Ther 1987; 242: 905-10
9. Choca JI, Green RD, Proudfit HK: Adenosine A1 and A2 receptors of substanita geratinosa are located predominantly on intrinsic neurons: an autontdiographic study. J Pharmacol Exp Ther 1988; 247: 757-64
10. Karlsten R, Post C, Hide I, Daly JW: The antinociceptive effect of intrathecally administered adenosine analogs in mice correlates with the affinity for the A1-adenosine receptor. Neurosci Lett 1991; 121: 267-70
11. Reeve AJ, Dickenson AH: Thee roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurons in the anesthetized rat. Br J Pharmacol 1995; 116: 2221-8
12. Zhuo QY, Li C, Olah ME, Johnson RA, Stiles GL, Civelli O: Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A 1992; 89: 7432-6
13. Stone TW: Receptors for adenosine and adenine nucleotides. Gen Pharmacol 1991; 22: 25-51
14. Collis MG, Hourani SMO: Adenosine receptor subtypes. Trends Pharmacol Sci 1993; 14: 360-6
15. Otsuka M, Konishi S: Electrophysiology of mammalian spinal cord in vitro. Nature 1974; 252: 733-4
16. Eccles JC, Schmidt R, Willis WD: Pharmacological studies on presynaptic inhibition. J Physiol 1963; 168: 500-30
17. Woodley SJ, Kendig JJ: Substance P and NMDA receptors mediate a slow nociceptive ventral root potential in neonatal rat spinal cord. Brain Research 1991; 559: 17-21
18. Chin JH, Crankshaw DP, Kendig JJ: Changes in the dorsal root potential with dizepam and with the analgesics aspirin, nitrous oxide, morphine and meperidine. Neuropharmacology 1974; 13: 305-15
19. Akagi H, Konishi S, Otsuku M: The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord. Br J Pharmacol 1985; 84: 663-73
20. Jewett BA, Gibbs LM, Tarasiuk A, Kendig JJ: Propofol and barbiturate depression of spinal nociceptive neurotransmission. ANESTHESIOLOGY 1992; 77: 1148-54
21. Megonigle P, Molinoff PB: Quantitative aspects of drug-receptor interactions, Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Edited by Siegel GJ. New York, Raven Press, 1989, pp 183-201
22. Arunlakshana O, Schild HO: Some quantitative uses of drug antagonists. Br J Pharmacol 1959; 14: 48-58
23. Sosnowski M, Stevens CW, Yaksh TL: Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord. J Pharmacol Exp Ther 1989; 250: 915-22
24. Ault B, Hildebrand LM: Effects of excitatory amino acid receptor antagonists on a capsaicin-evoked nociceptive reflex: a comparison with morphine, clonidine and baclofen. Pain 1993; 52: 341-9
25. Li J, Perl ED: Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J Neurophysiol 1994; 72: 1611-21
26. Salter MW, De KY, Henry JL: Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn [Review]. Prog Neurobiol 1993; 41: 125-56
27. Aran S, Proudfit HK: Antinociception produced by interactions between intrathecally administered adenosine agonists and norepi- nephrine. Brain Res 1990; 513: 255-63
28. van Galen PJM, van Bergen AH, Gallo-Rodriguez C, Olah ME, Ijzerman AP, Stiles GL, Jacobson KA: A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol 1994; 45: 1101-11
29. Dunwiddie TV: The physiological role of adenosine in the CNS. Int Rev Neurobiol 1985; 27: 103-24
30. Alzheimer C, Rohrenbeck J, ten Bruggencate G: Adenosine depressed induction of LTP at the mossy fiber-CA3 synapse in vitro. Brain Res 1991; 543: 163-5
31. Dunwiddie TV, Fredholm BB: Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J Pharmacol Exp Ther 1989; 249: 31-7
32. Uchiyama N, North A: Baclofen and adenosine inhibit synaptic potentials mediated by g-aminobutyric acid and glutamate release in rat nucleus accumbens. J Pharmacol Exp Ther 1991; 258: 663-8
33. Santicioli P, Del BE, Tramontana M, Maggi CA: Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide and substance P-like-immunoreactivities from primary afferents in rat spinal cord. Neurosci Lett 1992; 144: 211-4
34. Trussell LO, Jackson MB: Adenosine-activated potassium conductance in cultured striatal neurons. Proc Natl Acad Sci U S A 1985; 82: 4857-61
35. De Koninck Y, Henry JL: Peripheral vibration causes an adenosine-mediated postsynaptic inhibitory potential in dorsal horn neurons of the cat spinal cord. Neuroscience 1992; 50: 435-43
36. Hongo T, Jankowska E, Lundberg A: Postsynaptic excitation and inhibition from primary afferents on neurons of the spinocervecal tract. J Physiol Lond 1968; 199: 569-92
37. Evans RH, Long SK: Primary afferent depolarization in the rat spinal cord is mediated by pathways utilising NMDA and non-NMDA receptors. Neurosci Lett 1989; 100: 231-6
38. Dolphin AC, Prestwieh SA: Pertussis toxin reverses adenosine inhibition of neuronal glutamate release. Nature (Lond) 1985; 316: 148-50
39. Proctor WR, Dunwiddie TV: Pre- and post-synaptic actions of adenosine in the in vitro rat hippocampus. Brain Res 1987; 426: 187-90
40. Sehofield CN: Depression of evoked potentials in brain slices by adenosine compounds. Br J Pharmacol 1978; 63: 239-44
41. 3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther 1989; 251: 888-93